OR WAIT null SECS
February 02, 2014
Recent regulatory initiatives designed to secure the global pharmaceutical supply chain will directly impact the global supply chain and API manufacturers.
December 02, 2013
PIC/S reviews deficiencies found during inspections of API manufacturing facilities, harmonizes GMP standards, and provides training for inspectors worldwide.
November 02, 2013
Fine-chemical companies, contract manufacturers, and researchers advance chemocatalysis and biocatalysis.
October 10, 2013
With the enforcement of the European Directive 2011/62/EU relating to medicinal products for human use regarding falsified medicinal products, new requirements are introduced for active substances. The new regulation requires among other things, documentation of the supply chain traceability.
September 27, 2013
Cedarburg Hauser Pharmaceuticals has upgraded its API plant in Wisconsin.
September 11, 2013
New partnership aims to eliminate months from the typical transition time required to move chemistry from the laboratory into commercial applications.
September 01, 2013
Industry experts share their views on the outsourcing model and the current and future direction of contract chemical API manufacturing.
Commercial-scale amide formation and an improved process route for a tetracycline derivative are some recent developments in API synthesis.
August 14, 2013
A simple, rapid analytical method for the determination of palladium in pharmaceutical production samples will speed up development and optimization of reactions involving palladium catalysts.
August 01, 2013
Industry groups offered perspectives on the strengths and weaknesses of the European Falsified Medicines Directive.